The latest market report published by Credence Research, Inc. “Tuberculosis Diagnostics Market By Test Type (Radiographic Methods, Laboratory Methods, Nucleic Acid Testing, Phage Assay, Cytokine Detection Test, Detection Of Drug Resistance, Mantoux Test) - Growth, Future Prospects, and Competitive Analysis, 2017 - 2025,” the global tuberculosis diagnostics market was valued at US$ 2,220.9 Mn in 2016, and is expected to reach US$ 3,326.9 Mn by 2025 expanding at a CAGR of 4.5 % from 2017 to 2025.

Browse the full report at https://www.credenceresearch.com/report/tuberculosis-diagnostics-market

Market Insights

According to World Health organization in 2015 the MDR-TB reported cases were 480,000. The tuberculosis diagnostics kit has undergone tremendous technological advancement to give better accuracy, quick results, and available at low cost. For the purpose of this study, the global tuberculosis diagnostics market is segmented into test types which includes radiographic methods, laboratory methods, nucleic acid testing, phage assay, cytokine detection test, detection of drug resistance, and Mantoux test. In base year 2016, laboratory methods are leading the types segment due to rising prevalence of tuberculosis, easy collection of specimen sample and available at low cost. Nucleic acid testing, cytokine detection test segment is anticipated to register faster growth in the test types segment throughout the forecast period 2017-2025, as it is providing greater accuracy and requires less incubation period for the interpretation of the results. In 2016 Asia Pacific region dominated the tuberculosis diagnostics market due to factors such as large patient pool suffering with tuberculosis, government and non-government initiatives to eradicate tuberculosis and high disposable income in these regions. North America will register fastest growth throughout the forecast period 2017-2025, mainly due to factors such as rising public awareness regarding contagious diseases, advanced healthcare infrastructure and affordable reimbursement policies.

The tuberculosis diagnostics market is technologically driven and includes major players such as Thermo Fisher Scientific Corporation, Alere Inc., Abbott Laboratories, and Becton Dickinson and Company, among others are few market leaders in tuberculosis diagnostics market and compete to augment their foothold in the market.

Key Market Movements:

Higher prevalence of tuberculosis and MDR-TB
Technological advancement in the tuberculosis diagnostics market providing accuracy and quick result
Increasing government and non-government initiatives to eradicate tuberculosis
Affordable reimbursement policies
Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/58571

Table of Content

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Tuberculosis Diagnostics Market Portraiture
2.2 Global Tuberculosis Diagnostics Market, by Test Type 2016 Vs 2025 (US$ Mn)
2.3 Global Tuberculosis Diagnostics Market, by Geography, 2016 (Value %)

Chapter 3 Global Tuberculosis Diagnostics Market: Market Dynamics and Future Outlook
3.1 Overview
3.2 Market Drivers
3.2.1 Rising prevalence of Tuberculosis
3.2.2 For a full, detailed list, browse our report
3.3 Market Restraints
3.3.1 Costly diagnosis and lack of skilled labor to perform accurate diagnosis will hinder the growth of tuberculosis diagnostic market
3.3.2 For a full, detailed list, browse our report
3.4 Market Opportunities
3.4.1 Increasing number of patients reported with MDR-TB and hospital acquired infection
3.4.2 For a full, detailed list, browse our report
3.5 Attractive Investment Proposition
3.6 Market Competition Assessment: Global Tuberculosis Diagnostics Market, by Key Players

Chapter 4 Global Tuberculosis Diagnostics Market, by Test Type, 2015-2025 (US$ Mn)
4.1 Introduction
4.2 Radiographic Methods
4.3 Laboratory Methods
4.3.1 Smear Microscopy
4.3.2 Culture Based Test
4.4 Nucleic Acid Testing
4.5 Phage Assay
4.6 Cytokine Detection Test
4.7 Detection of Drug Resistance
4.8 Mantoux Test

Chapter 5 Global Tuberculosis Diagnostics Market, by Geography, 2015-2025 (US$ Mn)
5.1 Preface
5.2 North America
5.2.1 North America Tuberculosis Diagnostics Market,by Test Type, 2015-2025 (US$ Mn)
5.2.2 North America Tuberculosis Diagnostics Market,by Country, 2015-2025 (US$ Mn)
5.2.2.1 U.S.
5.2.2.2 Canada
5.3 Europe
5.3.1 Europe Tuberculosis Diagnostics Market,by Test Type, 2015-2025 (US$ Mn)
5.3.2 Europe Tuberculosis Diagnostics Market,by Country, 2015-2025 (US$ Mn)
5.3.2.1 U.K.
5.3.2.2 Germany
5.3.2.3 Rest of Europe
5.4 Asia Pacific
5.4.1 Asia Pacific Tuberculosis Diagnostics Market, by Test Type, 2015-2025 (US$ Mn)
5.4.2 Asia Pacific Tuberculosis Diagnostics Market,by Country, 2015-2025 (US$ Mn)
5.4.2.1 China
5.4.2.2 Japan
5.4.2.3 Rest of Asia Pacific
5.5 Latin America
5.5.1 Latin America Tuberculosis Diagnostics Market,by Test Type, 2015-2025 (US$ Mn)
5.5.2 Latin America Tuberculosis Diagnostics Market,by Country, 2015-2025 (US$ Mn)
5.5.2.1 Brazil
5.5.2.2 Mexico
5.5.2.3 Rest of Latin America
5.6 Middle East and Africa
5.6.1 Middle East and Africa Tuberculosis Diagnostics Market,by Test Type, 2015-2025 (US$ Mn)
5.6.2 Middle East and Africa Tuberculosis Diagnostics Market,by Country, 2015-2025 (US$ Mn)
5.6.2.1 GCC
5.6.2.2 Rest of Middle East and Africa

Chapter 6 Company Profiles
6.1 Abbott Laboratories
6.2 Alere, Inc.
6.3 Becton Dickinson and Company
6.4 bioMérieux SA
6.5 Cepheid Inc.
6.6 Epistem plc
6.7 F. Hoffman La Roche AG
6.8 Hain Lifescience GmbH
6.9 Hologic Corporation
6.10 Thermo Fisher Scientific, Inc.
6.11 QIAGEN

Medium Blog: https://medium.com/@kumarganeshtr/tuberculosis-diagnostics-market-is-expected-to-reach-us-3-326-9-mn-by-2025-fa0b6b39857c